Adalimumab: A ‘Maillon Faible’ in the Treatment of Ulcerative Colitis?

Saved in:

Bibliographic Details
Published in	Journal of Crohn's and colitis Vol. 18; no. 3; pp. 337 - 338
Main Authors	Roblin, Xavier, Paul, Stephane
Format	Journal Article
Language	English
Published	England Elsevier - Oxford University Press 01.03.2024
Subjects	Adalimumab - therapeutic use Anti-Inflammatory Agents - therapeutic use Antibodies, Monoclonal, Humanized - therapeutic use Colitis, Ulcerative - drug therapy Human health and pathology Humans Immunology Infectious diseases Life Sciences Microbiology and Parasitology Pharmaceutical sciences Pharmacology Prospective Studies Vaccinology Virology
Online Access	Get full text
ISSN	1873-9946 1876-4479 1876-4479
DOI	10.1093/ecco-jcc/jjad167

More Information
Bibliography:	SourceType-Scholarly Journals-1 content type line 23 ObjectType-Editorial-2 ObjectType-Commentary-1
ISSN:	1873-9946 1876-4479 1876-4479
DOI:	10.1093/ecco-jcc/jjad167